Literature DB >> 24164766

The relation of co-occurring musculoskeletal pain and depressive symptoms with work ability.

Rahman Shiri1, Leena Kaila-Kangas, Kirsi Ahola, Teija Kivekäs, Eira Viikari-Juntura, Markku Heliövaara, Helena Miranda, Päivi Leino-Arjas.   

Abstract

OBJECTIVE: To examine the relationship of musculoskeletal pain and depressive symptoms, occurring alone or both together, with self-rated current work ability and thoughts of early retirement.
METHODS: In a nationally representative sample drawn in 2000-2001, we studied actively working subjects aged 30 to 64 years (n = 4009).
RESULTS: Musculoskeletal pain was associated with moderate/poor physical work ability (adjusted odds ratio [OR] = 2.9; 95% confidence interval [CI], 2.0 to 4.2) and mental work ability (OR = 1.6; 95% CI, 1.2 to 2.2). Depressive symptoms were associated with moderate/poor mental work ability only (adjusted OR = 4.2; 95% CI, 2.3 to 7.9). Moreover, only musculoskeletal pain was associated with thoughts of early retirement (OR = 1.4; 95% CI, 1.1 to 1.8). There was an interaction between musculoskeletal pain and depressive symptoms regarding physical work ability and thoughts of early retirement.
CONCLUSION: Co-occurrence of musculoskeletal pain and depressive symptoms is strongly related to poor self-rated physical work ability.

Entities:  

Mesh:

Year:  2013        PMID: 24164766     DOI: 10.1097/JOM.0b013e3182a4ffc4

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  7 in total

1.  Efficacy of temporary work modifications on disability related to musculoskeletal pain or depressive symptoms--study protocol for a controlled trial.

Authors:  Eija Haukka; Kari-Pekka Martimo; Teija Kivekäs; Ritva Horppu; Tea Lallukka; Svetlana Solovieva; Rahman Shiri; Irmeli Pehkonen; Esa-Pekka Takala; Ellen MacEachen; Eira Viikari-Juntura
Journal:  BMJ Open       Date:  2015-05-18       Impact factor: 2.692

2.  Headache: an important factor associated with muscle soreness/pain at the two-year follow-up point among patients with major depressive disorder.

Authors:  Ching-I Hung; Chia-Yih Liu; Ching-Hui Yang; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2016-05-27       Impact factor: 7.277

3.  Effectiveness of internet-delivered cognitive behavioural therapy in reducing sickness absence among young employees with depressive symptoms: study protocol for a large-scale pragmatic randomised controlled trial.

Authors:  Anne Kouvonen; Minna Mänty; Jaakko Harkko; Hilla Sumanen; Hanna Konttinen; Jouni Lahti; Olli Pietilainen; Jenni Blomgren; Eevamaija Tuovinen; Eeva-Leena Ketonen; Jan-Henry Stenberg; Michael Donnelly; Børge Sivertsen; Ellenor Mittendorfer-Rutz; Sami Pirkola; Ossi Rahkonen; Tea Lallukka
Journal:  BMJ Open       Date:  2019-11-05       Impact factor: 2.692

4.  Reliability and construct validity of the modified Finnish version of the 9-item patient health questionnaire and its associations within the biopsychosocial framework among female health-care workers with sub-acute or recurrent low back pain.

Authors:  J H Suni; T Virkkunen; P Husu; K Tokola; J Parkkari; M Kankaanpää
Journal:  BMC Musculoskelet Disord       Date:  2021-01-07       Impact factor: 2.362

5.  Depressive Symptoms Are Associated With Decreased Quality of Life and Work Ability in Currently Working Health Care Workers With Recurrent Low Back Pain.

Authors:  Tarja Virkkunen; Pauliina Husu; Kari Tokola; Jari Parkkari; Markku Kankaanpää
Journal:  J Occup Environ Med       Date:  2022-06-11       Impact factor: 2.306

6.  Work-related diabetes distress among Finnish workers with type 1 diabetes: a national cross-sectional survey.

Authors:  Pirjo Hakkarainen; Leena Moilanen; Vilma Hänninen; Jarmo Heikkinen; Kimmo Räsänen
Journal:  J Occup Med Toxicol       Date:  2016-03-21       Impact factor: 2.646

7.  Factors associated with quality of life and work ability among Finnish municipal employees: a cross-sectional study.

Authors:  Elina Bergman; Eliisa Löyttyniemi; Saana Myllyntausta; Päivi Rautava; Päivi Elina Korhonen
Journal:  BMJ Open       Date:  2020-09-23       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.